Hawley Hammers McKinsey, Blasts Company for its China Ties & Role in Opioid Epidemic

Tuesday, February 06, 2024

Today in a Homeland Security and Governmental Affairs subcommittee hearing on foreign influence in the United States, Senator Josh Hawley (R-Mo.) called out McKinsey & Company for its litany of contracts with companies engaged with the Chinese Communist Party (CCP).

“If [McKinsey] is going to advise foreign nations who are hostile to us and make gobs of money off of them, why should you be getting U.S. government contracts?” Senator Hawley asked Bob Sternfels, Global Managing Partner of McKinsey & Company.

“Your work right now, taking money from this government, as you help the Chinese Communist Party is absolutely unforgivable, and I will not rest until it is illegal,” he concluded.

Watch clip here or above. 

Senator Hawley also hammered McKinsey & Company’s contribution to the ongoing opioid epidemic in Missouri and across the U.S.

“Since I represent the state of Missouri that has been absolutely devastated by the opioid crisis—and I know you know a lot about that because speaking of money, McKinsey had made an unbelievable amount of money off of the opioid crisis,” said Senator Hawley.

He continued, “You don’t think marketing these drugs to doctors and children helped cause the epidemic? You don’t think [McKinsey] has any part in that?”

Watch clip here or above.

Senator Hawley has previously introduced the Time to Choose Act which would prohibit the Department of Defense and other federal agencies from contracting with consulting firms like McKinsey & Company who are simultaneously providing services to the Chinese government or its affiliates. The bill would force these government contractors to choose whether to stand with the United States in its efforts to protect Americans against China’s imperial ambitions, or forfeit U.S. government contracts.

In 2020, Senator Hawley sent a letter to McKinsey & Company, blasting its proposal to ensure sales of Purdue Pharma’s OxyContin by paying pharmacies bounties for opioid overdoses.

Issues